- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 23
Background: Drugs Targeting The Renin System May Not Be Clinically Equivalent
Evidence on Adverse Effects
Results of Trials Evaluating the Addition of an ACEI or an ARB to Standard Therapy for Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Overall Summary of the Evidence-Based Benefits and Harms of Adding an ACEI/ARB Combination Versus an ACEI Alone to Standard Medical Therapy for Stable Ischemic Heart Disease With Preserved Left Ventricular Systolic Function
Background: Additional Issues
Findings of the Comparative Effectiveness Review: Medication (2 of 3)
Findings of the Comparative Effectiveness Review: Surgery (2 of 3)
Knowledge Gaps and Future Research Needs
Adverse Events of Treatment
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | adverse effects | treatment | withdrawal | hypotension | cough | edema | hyperkalemia
Conclusions: Treatment (2 of 2)
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: ACEI | adverse events | ARB | conclusions | outcomes | statin | chronic kidney disease
Patient Discussion: Potential Harms of ACEIs
Your slide tray is being processed.